Cannabix Technologies (BLOZF) Stock Price, News & Analysis

Company Overview

Cannabix Technologies Inc. is a Canada-based developer of bio­sensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.

The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis. In addition to its cannabis detection platform, the company is exploring integration of alcohol and multi-drug screening capabilities to create a more comprehensive roadside and occupational testing solution. Cannabix has pursued partnerships with research institutions and regulatory bodies to validate its technology under controlled conditions.

Headquartered in Vancouver, British Columbia, Cannabix Technologies conducts its research and development activities at its Canadian laboratories and collaborates with external contract manufacturers for product assembly. The company’s management team is led by Chief Executive Officer Craig Ellins, who brings experience in technology commercialization and regulatory affairs. The board and executive suite also include professionals with backgrounds in biosensor engineering, public safety and diagnostics marketing.

As a publicly traded entity on the OTC Markets under the symbol BLOZF, Cannabix Technologies continues to advance its prototype toward regulatory approval and commercial rollout. Its primary markets include North America and select international jurisdictions considering roadside and workplace drug screening solutions, with ongoing efforts to secure government contracts and private-sector distribution agreements.

Key Stats

• Today's Range: $0.36 to $0.37
• 50-Day Range: $0.36 to $0.43
• 52-Week Range: $0.31 to $0.68
• Volume: 22,782 shs
• Average Volume: 108,570 shs
• Market Capitalization: $45.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 12/30/2025
• Today: 8/26/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:BLOZF
• CIK: N/A
• Web: www.cannabixtechnologies.com
• Phone: 604-551-7831
• Fax: 604-676-2767
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.36 million
• Net Margins: N/A
• Pretax Margin: -3,920.00%
• Return on Equity: -300.86%
• Return on Assets: -258.30%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.44
• Quick Ratio: 5.99

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.02 per share
• Price / Book: 18.35

Miscellaneous

• Outstanding Shares: 122,840,000
• Free Float: N/A
• Market Cap: $45.08 million
• Optionable: Not Optionable
• Beta: 1.02